Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. How long can I stay on cyclosporine?

    Cyclosporine is an immunosuppressive drug that works by preventing ... anemia patients may require prolonged ongoing treatment with cyclosporine to prevent or minimize the risk of disease relapse aplastic anemia coming back. Generally speaking, patients can remain on cyclosporine indefinitely, as long as there is evidence that the drug is ...

    FAQ last updated 03/15/2016 - 11:49pm.

  2. StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

    ... Cyclophosphamide Cyclosporine Filgrastim Fludarabine ...

    Clinical Trial last updated 06/03/2016 - 2:37pm.

  3. What are the side effects of cyclosporine?

    Cyclosporine is a drug that lowers your body's immune response. Cyclosporine is used along with antithymocyte globulin (ATG), another ... bone marrow failure diseases. If you are taking cyclosporine as part of your treatment regimen, your doctor should monitor you ...

    FAQ last updated 03/15/2016 - 11:48pm.

  4. Phase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome

    ... 14, subjects will receive hATG, Methylprednisolone and Cyclosporine . From Day 15 until Day 30 (of the first month), subjects will continue treatment only with Methylprednisolone and Cyclosporine. Cyclosporine will continue daily through Month 6/Day 30 (M6/D30) ...

    Clinical Trial last updated 04/26/2016 - 11:45am.

  5. "Moderate" dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution

    ... to IST with horse anti-thymocyte globulin (h-ATG) and cyclosporine . Despite various efforts to improve IST results, horse ATG plus cyclosporine is still the regimen with better outcomes and is thus the standard ...

    Research Review last updated 05/02/2016 - 9:13am.

  6. CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

    ... normal cells (called graft-versus-host disease). Giving cyclosporine and mycophenolate mofetil after the transplant may stop this ... immune suppression therapy with either tacrolimus or cyclosporine at the time of CD8+ memory T-cell infusion; prednisone ...

    Clinical Trial last updated 04/29/2016 - 12:36pm.

  7. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... use of lower doses of busulfan and the elimination of cyclosporine will further reduce transplant-related side effects for ...

    Clinical Trial last updated 05/09/2016 - 3:19pm.

  8. Intra-Osseous Co-Transplant of UCB and hMSC

    ... immune response against the body's normal cells. Giving cyclosporine and mycophenolate mofetil at the time of transplant may stop ... Cyclophosphamide Cyclosporine Fludarabine Mycophenolate ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  9. Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

    ... together with total-body irradiation followed by cyclosporine and mycophenolate mofetil before the transplant may stop this ... chemotherapy together with radiation therapy followed by cyclosporine and mycophenolate mofetil works in treating patients who are ...

    Clinical Trial last updated 05/02/2016 - 2:20pm.

  10. Total Marrow Irradiation for Refractory Acute Leukemia

    ... immune response against the body's normal cells. Giving cyclosporine and mycophenolate mofetil after the transplant may stop this ... Cyclophosphamide Cyclosporine Fludarabine ...

    Clinical Trial last updated 05/02/2016 - 9:22am.